首页 | 本学科首页   官方微博 | 高级检索  
     

Novel phototherapeutic agents: Investigation and progress of hypocrellin derivatives
引用本文:XUShancgjie ZHANGXiaoxing CHENShen ZHANGManhua SHENTao WANGZhengping. Novel phototherapeutic agents: Investigation and progress of hypocrellin derivatives[J]. 科学通报(英文版), 2003, 48(17): 1775-1785. DOI: 10.1007/BF03184053
作者姓名:XUShancgjie ZHANGXiaoxing CHENShen ZHANGManhua SHENTao WANGZhengping
作者单位:[1]CenterforPhotochemistry,InstituteofChemistry,ChineseAcademyofSciences,Beijing100080,China [2]DepartmentofChemicalEngineer,HarbinEngineeringUniversity,Harbin150001,China
摘    要:Hypocrellins, as a kind of novel phototherapeutic agents, have several advantages over the clinically used hematoporphyrin derivatives, including high-excited triplet state yield, high phototoxicity, low dark toxicity, and rapid metabolism. However, they exhibit little absorption in the photodynamic window (600--900 nm) and are not water soluble, which limits their application in photodynamic therapy. Sulfonated and metal-ioned hypocrellins have been designed and synthesized to improve their water solubility.Unfortunately, the water-soluble derivatives obtained exhibit lower photodynamic activity than the parent hypocrellins.Thiolated and aminated hypocrellins have also been designed and synthesized to enlarge their photoresponse. Among them,the aminated hypocrellins possess the highest photodynamic activity. We recently have further designed and synthesized some amphiphilic aminated hypocrellin derivatives. Thus,not only the photoresponse but also the water solubility is enhanced. The experiments in vitro and in vivo on the derivatives are under way at present.

关 键 词:光动力性疗法 光敏剂 纯态氧 过氧离子团 电子顺磁共振
收稿时间:2003-01-07
修稿时间:2003-04-02

Novel phototherapeutic agents: Investigation and progress of hypocrellin derivatives
Shangjie?Xu,Xiaoxing?ZhangEmail author,Shen?Chen,Manhua?Zhang,Tao?Shen,Zhengping?Wang. Novel phototherapeutic agents: Investigation and progress of hypocrellin derivatives[J]. Chinese science bulletin, 2003, 48(17): 1775-1785. DOI: 10.1007/BF03184053
Authors:Shangjie?Xu,Xiaoxing?Zhang  author-information"  >  author-information__contact u-icon-before"  >  mailto:tshen@infoc.icas.ac.cn"   title="  tshen@infoc.icas.ac.cn"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Shen?Chen,Manhua?Zhang,Tao?Shen,Zhengping?Wang
Affiliation:XU Shangjie1, ZHANG Xiaoxing2, CHEN Shen1, ZHANG Manhua1, SHEN Tao1 & WANG Zhengping2 1. Center for Photochemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China; 2. Department of Chemical Engineer, Harbin Engineering University, Harbin 150001, China
Abstract:Hypocrellins, as a kind of novel phototherapeutic agents, have severaladvantages over the clinically used hematoporphyrin derivatives, including high-excited triplet state yield, high phototoxicity, low dark toxicity, and rapid metabolism. However, they exhibit little absorption in the photodynamic window (600-900 nm) and are not water soluble, which limits their application in photodynamic therapy. Sulfonated and metal-ioned hypocrellins have been designed and synthesized to improve their water solubility. Unfortunately, the water-soluble derivatives obtained exhibit lower photodynamic activity than the parent hypocrellins. Thiolated and aminated hypocrellins have also been designed and synthesizedto enlarge their photoresponse. Among them, the aminated hypocrellins possess the highest photodynamic activity. We recently have further designed and synthesized some amphiphilic aminated hypocrellin derivatives. Thus, not only the photoresponse but also the water solubility is enhanced. The experiments in vitro and in vivo on the derivatives are under way at present.
Keywords:photodynamic therapy   EPR   hypocrellins  singlet oxygen   superoxide anion radical.
本文献已被 CNKI 维普 万方数据 SpringerLink 等数据库收录!
点击此处可从《科学通报(英文版)》浏览原始摘要信息
点击此处可从《科学通报(英文版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号